glp 1 agonists and pancreatitis GLP-1–Based Therapies: The Dilemma of Uncertainty Frontiers | Association between different

A dose of intravenous erythromycin (200-300mg) promotes gastric motility [9] , while metoclopramide increases digestive system movements [10]

in clinical studies, an increase in hypoglycemia incidence was only observed in tirzepatide-treated patients if they had a comedication with insulin and/or oral insulinotropic agents (sulfonylurea) (61)

Mahaffey KW, Hafley G, Dickerson S, et al

However, the long-term implications of prolonged GLP-1 medication use remain a topic of ongoing research and debate, Thompson says

Every bit of additional absorption improves the effective dose you receive

If berberine is your primary choice and based on the evidence, its a reasonable one formulation details matter more than most people realize